Recent Promotions

TNKS Knockout HEK293 Cell Line

TNKS Knockout HEK293 Cell Line
Cat.No.:

EDJ-KQ6320

Species:

Human

Cell Name:

HEK293

Gene:

TNKS

Gene ID:

8658

Size:

1×10⁶cells

TNKS Knockout Cell Line (HEK293) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
Cat.No. EDJ-KQ6320
Product Name TNKS Knockout Cell Line(HEK 293)
Cell Line HEK293
Cellosaurus ID CVCL_0045
Cell Line Synonyms Hek293, HEK-293, HEK/293, (HEK)293, HEK 293, HEK,293, 293, 293 HEK, 293 Ad5, Graham 293, Graham-293, Human Embryonic Kidney 293
Gene
NCBI Gene ID
Gene Synonyms ARTD5|PARP-5a|PARP5A|PARPL|TIN1|TINF1|TNKS1|pART5
Summary
Enables histone binding activity; pentosyltransferase activity; and zinc ion binding activity. Involved in several processes, including positive regulation of canonical Wnt signaling pathway; post-translational protein modification; and regulation of chromosome organization. Acts upstream of or within peptidyl-serine phosphorylation and peptidyl-threonine phosphorylation. Located in several cellular components, including chromosome, telomeric region; mitotic spindle pole; and nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Associated Diseases Non-tumor
Morphology Adherent
Passage Ratio 1/5,2days
Complete Culture Medium DMEM + 10% FBS
Freezing Medium 95% Complete culture medium+ 5% DMSO
QC Indels validated by Sanger sequencing; sterility confirmed via microbial testing.
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
LociSTR Info (Sample Cell)
Sample Cell Line: HEK293
STR Info (Cell bank)
Cell Line: HEK293
Allele1Allele2Allele1Allele2
Amelogenin X X
CSF1P0 12 11 12
D2S1338 19 19
D3S1358 15 17 15 17
D5S818 8 8 9
D7S820 11 12 11 12
D8S1179 12 14 12 14
D13S317 12 14 12 14
D16S539 9 13 9 13
D18S51 17 18 17 18
D19S433 15 18 15 18
D21S11 28 30.2 28 30.2
FGA 23 23
Penta D 9 10 9 10
Penta E 7 15 7 15
TH01 7 9.3 7 9.3
TPOX 11 11
vWA 16 19 16 19
D6S1043 11 11
D12S391 19 21 11 15
D2S441 11 15 11 15
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.

Research Publications

IF=3.8
Journal of virology
Influenza viruses are respiratory pathogens that cause both seasonal and unpredictable pandemic infections in humans. Currently approved anti-influenza drugs target the viral proteins. A recurrent mutation in the influenza genome leads to drug resistance and thus hinders the efficacy of anti-influenza drug treatments. Influenza A virus (IAV) depends on host factors to complete its virus life cycle. Thus, there are increasing interests in antiviral drugs that target host cellular proteins required for virus replication. Poly (ADP-ribose) polymerases (PARPs) are the host factors that modify protein functions by adding ADP-ribose to target proteins. Using the CRISPR activation system, we screened all 17 PARP members for its effects on IAV infection in lung epithelial A549 cells. Tankyrase 1 and 2 (TNKS 1/2 or PARP5A/5B) were found to be potent proviral factors. Knockout of TNKS1 or TNKS2 in HEK293T cells by CRISPR reduced viral mRNA and protein levels in cells and viral titers in culture media. Double knockout of TNKS1 and TNKS2 had a larger effect on IAV infection than single knockout of each isoform. The effect of TNKS double knockout on IAV replication was strain independent. Overexpression of TNKS1/2 in the double knockout cells restored the IAV replication to a level similar to the control cells. TNKS double knockout activated JNK/c-Jun signaling, enhanced Stat signaling, and increased type I interferon expression. Finally, or KO mice challenged with a sublethal IAV showed increased type I IFN response and reduced viral load in the lungs. The survival rate of or KO mice from a lethal IAV infection was significantly increased compared to wild-type mice. In conclusion, TNKS1 and TNKS2 regulate influenza virus infection via type I interferon response.IMPORTANCEPoly (ADP-ribose) polymerases (PARPs) play a crucial role in DNA repair, cellular stress responses, epigenetics, gene transcription, and viral infections. However, the specific roles of PARPs in influenza A virus (IAV) infection remain unclear. In this study, we identified Tankyrase 1 and 2 (TNKS1/2 or PARP5a/5b) as the potent proviral factors. Knockout of TNKS1 or TNKS2 reduced viral replication , with the double knockout showing an even greater effect. TNKS double knockout also resulted in an increased type I interferon response to IAV infection. , Tnks1 or Tnks2 KO mice exhibited lower viral loads and higher survival rates following IAV challenge. Our findings highlight TNKS1/2 as important regulators of IAV infection and potential targets for antiviral therapies.
This KO model may be useful for: - Investigating the role of tankyrases in viral replication, particularly influenza A virus - Studying the regulation of type I interferon signaling pathways - Screening antiviral compounds targeting TNKS-dependent mechanisms - Exploring host-virus interaction and innate immune evasion strategies - Functional validation of TNKS in immune response modulation

Recommended Accessories

Related Products

Flash CRISPR Knockout Kit(Universal Version)Flash CRISPR Knockout Kit(Universal Version)
Flash-Pro CRISPR KO Kit (For Organoids / Stem Cells)Flash-Pro CRISPR KO Kit (For Organoids / Stem Cells)

Related Services

Knockout Cell LineKnockout Cell Line
Contact Us
*
*
*
How did you hear about us: